German hospital treats U.S. Ebola patient infected in Congo

A United States citizen working for a humanitarian organization in the Democratic Republic of Congo (DRC) was admitted to Frankfurt University Hospital early on Monday, for treatment of the Ebola virus. The patient, a man in his 60s employed as a warehouse manager for the Christian aid group Samaritan’s Purse, arrived at the facility's special isolation unit at approximately 3 a.m. Local time.

The patient has been diagnosed with the Bundibugyo variant of the Ebola virus. Timo Wolf, the head of the hospital’s special isolation unit, described the patient's condition as stable. Hospital officials have emphasized that there is no risk to the general public or other patients, noting that the individual is held in a unit that is both structurally and organizationally separated from the rest of the facility.

Related imagery

Outbreak Expansion and Data

The arrival of the patient in Germany coincides with an escalation of the Ebola outbreak within the Democratic Republic of Congo. Official reports from the country's public health institute indicate that the total number of confirmed cases has risen to 1,926, with 702 deaths attributed to the disease. The virus has officially spread into two additional provinces: Haut-Uele and Tshopo. According to the National Institute of Public Health, while investigations suggest that the cases appearing in these new regions are primarily imported from Niania in Ituri, both provinces are now considered part of the epidemic zone as of the report dated 11 July 2026.

The current situation follows an earlier incident involving an American doctor, 39-year-old Peter Stafford, who contracted the same variant of the virus in the DRC. Dr. Stafford was treated at Charité hospital in Berlin after being evacuated in May 2026 and was discharged in June following a recovery that medical staff characterized as a significant therapeutic success. Unlike the current patient, Dr. Stafford received experimental therapies during his intensive treatment.

Context and Containment Challenges

The current outbreak is the 17th to affect the Congo, having been officially declared on 15 May 2026. Health experts have raised concerns regarding the true scale of the epidemic, with some World Health Organization officials suggesting that the actual number of cases could be two to four times higher than official figures, as many new cases lack a known link to previously confirmed patients.

The Bundibugyo variant remains a significant concern for health authorities as there is currently no approved vaccine specifically for this strain. The disease, which typically causes symptoms such as high fever, muscle pain, vomiting, and in severe cases, internal and external bleeding, is transmitted through direct contact with infected bodily fluids.

International response efforts remain ongoing. An official from Samaritan’s Purse expressed hope for a positive outcome for the warehouse manager, noting that the patient had received early treatment. Diplomatic arrangements were made by the U.S. Department of State to facilitate the evacuation.

Recent Timeline of Medical Evacuations

• 15 May 2026: DRC authorities officially declare the current Ebola outbreak in Ituri Province.
• 20 May 2026: American surgeon Peter Stafford is admitted to Charité hospital in Berlin after contracting the virus.
• 6 June 2026: Dr. Stafford is discharged from the Berlin hospital following recovery.
• 11 July 2026: The National Institute of Public Health officially classifies Haut-Uele and Tshopo as epidemic zones.
• 13 July 2026: A second U.S. Citizen, a humanitarian worker, is admitted to Frankfurt University Hospital.

The U.S. Centers for Disease Control and Prevention continues to work with international partners to identify close contacts of those infected to prevent further transmission.